Please provide your email address to receive an email when new articles are posted on . As catheter-directed therapies have advanced in recent years, they are becoming a critical part of the strategy ...

There are several closely watched randomized trials examining catheter-directed therapies for acute pulmonary embolism, according to Parth Rali, MD, an associate professor of thoracic medicine and ...

One in 6 patients hospitalized for a first episode of syncope experiences a pulmonary embolism. Pulmonary embolism occurs in approximately 1 in 6 patients who are hospitalized for a first episode of ...

Bayer's Xarelto® (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism (PE) and the Prevention of Recurrent Deep Vein Thrombosis (DVT) and PE in the EU Blood clots obstructing blood flow in ...

Results of EXTRACT-PE Trial presented at Vascular InterVentional Advances (VIVA) Annual Meeting “The Indigo Aspiration System has demonstrated tremendous potential to address patients with clot in ...

MIAMI BEACH, FL—Pulmonary embolism (PE), an often-deadly condition that’s best served by a multidisciplinary approach to care, is the perfect target for artificial intelligence (AI), according to ...

Approximately one in six patients hospitalized for a first episode of syncope have a pulmonary embolism, a new study shows, with the prevalence of pulmonary embolism highest among individuals without ...

Thrombolysis is an accepted practice for treating massive pulmonary embolism and hemodynamic instability. These authors evaluated whether thrombolysis is also effective for patients with submassive ...

Pulmonary embolism can be difficult to treat. Its implications can range from relatively benign to life-threatening and treatments range from medical management to endovascular intervention to major ...

A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.

The ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been caused by the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has significantly affected the ...

Dublin, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The "Pulmonary Embolism Market - A Global and Regional Analysis, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global pulmonary embolism ...